SIBIONICS présente le GS3 à Melbourne, pour une surveillance de la glycémie plus efficace et activée par l'intelligence artificielle

ConferenceGS3Positive

AI Analysis

SIBIONICS presented its GS3 glucose monitoring system with AI capabilities at the IDF-WPR, ADC and Metabolic Diseases 2026 congress in Melbourne.

Importance:4/10

Sentiment:

0.30

glucose monitoringartificial intelligencecontinuous glucose monitordiabetes management

Read the original article

Published by PR Newswire Pharma on September 1, 2026 7:53 AM